Bilbao-Asensio, M. (2022). Chemically programming redox-active nanovaccines and theranostic nanoparticles for combination cancer immunotherapy. Swansea.
Chicago Style CitationBilbao-Asensio, Marc. Chemically Programming Redox-active Nanovaccines and Theranostic Nanoparticles for Combination Cancer Immunotherapy. Swansea, 2022.
MLA CitationBilbao-Asensio, Marc. Chemically Programming Redox-active Nanovaccines and Theranostic Nanoparticles for Combination Cancer Immunotherapy. Swansea, 2022.
Warning: These citations may not always be 100% accurate.